MENU
+Compare
VRDN
Stock ticker: NASDAQ
AS OF
Sep 26, 12:21 PM (EDT)
Price
$19.52
Change
+$0.44 (+2.31%)
Capitalization
1.56B

VRDN Viridian Therapeutics Forecast, Technical & Fundamental Analysis

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VRDN with price predictions
Sep 24, 2025

VRDN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for VRDN moved above the 200-day moving average on August 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where VRDN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRDN advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 160 cases where VRDN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VRDN as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VRDN turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRDN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VRDN broke above its upper Bollinger Band on September 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VRDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.776) is normal, around the industry mean (19.844). P/E Ratio (0.000) is within average values for comparable stocks, (54.097). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.112). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. VRDN's P/S Ratio (5000.000) is very high in comparison to the industry average of (344.917).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VRDN is expected to report earnings to fall 4.50% to -95 cents per share on November 18

Viridian Therapeutics VRDN Stock Earnings Reports
Q3'25
Est.
$-0.95
Q2'25
Est.
$-1.00
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.22
Q3'24
Missed
by $0.09
The last earnings report on August 06 showed earnings per share of -100 cents, meeting the estimate of -100 cents. With 17.17K shares outstanding, the current market capitalization sits at 1.56B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVWSX28.68N/A
N/A
Fidelity Series Opportunistic Insights
IICHX12.23N/A
N/A
AMF Large Cap Equity H
DDERX15.90-0.06
-0.38%
Macquarie Wealth Builder R6
FSBCX21.54-0.09
-0.42%
Federated Hermes Global Allocation C
PVEJX15.97-0.11
-0.68%
Principal MidCap Value I J

VRDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-2.05%
SYRE - VRDN
58%
Loosely correlated
-8.18%
CRNX - VRDN
56%
Loosely correlated
+2.05%
NUVL - VRDN
55%
Loosely correlated
-2.54%
BEAM - VRDN
52%
Loosely correlated
-2.08%
OCUL - VRDN
52%
Loosely correlated
-2.51%
More